Cargando…
Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma
Malignant mesothelioma (MM) is an aggressive malignancy, highly resistant to current medical and surgical therapies, whose tumor cells characteristically show a high level of aneuploidy and genomic instability. We tested our hypothesis that targeting chromosomal instability in MM would improve respo...
Autores principales: | Szymiczek, Agata, Carbone, Michele, Pastorino, Sandra, Napolitano, Andrea, Tanji, Mika, Minaai, Michael, Pagano, Ian, Mason, Jacqueline M., Pass, Harvey I., Bray, Mark R., Mak, Tak W., Yang, Haining |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690838/ https://www.ncbi.nlm.nih.gov/pubmed/28759042 http://dx.doi.org/10.1038/onc.2017.266 |
Ejemplares similares
-
Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma
por: Carbone, Michele, et al.
Publicado: (2016) -
FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model
por: Szymiczek, Agata, et al.
Publicado: (2017) -
Preventive and therapeutic opportunities: targeting BAP1 and/or HMGB1 pathways to diminish the burden of mesothelioma
por: Carbone, Michele, et al.
Publicado: (2023) -
Evaluation of clonal origin of malignant mesothelioma
por: Comertpay, Sabahattin, et al.
Publicado: (2014) -
Heterozygous germline BLM mutations increase susceptibility to asbestos and mesothelioma
por: Bononi, Angela, et al.
Publicado: (2020)